Tango Therapeutics
TNGX
21.83
-0.07
-0.32%
Tango Therapeutics
US · TNGX
#2322 by market cap
Listed 1970
21.83
-0.07
-0.32%
Live - 5344 symbols - heartbeat 244s ago
· 2026-10-08 06:07
Pre-market
21.69
-0.64%
After-hours
21.83
0.00%
- Market cap
- 3.68B
- P/E (TTM)i
- -25.99
- P/Bi
- 3.59
- EPSi
- -0.87
- Div yieldi
- 0.00%
- 52W posi
- 55%
Reader sentiment
Are you bullish or bearish on TNGX?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 6 analysts
Buy
Avg price target
45.67 +109.2%
Price target rangecurrent 21.83
Low35.00
Avg45.67
High68.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-24 | CCORF | -- | BUY | 46.00 |
| 2026-09-24 | Guggenheim | -- | BUY | 35.00 |
| 2026-09-11 | CCORF | -- | BUY | 46.00 |
| 2026-08-18 | H.C. Wainwright | -- | BUY | 68.00 |
| 2026-08-17 | Stifel | -- | BUY | 40.00 |
| 2026-08-12 | CCORF | -- | BUY | 46.00 |
| 2026-08-12 | Wedbush | -- | BUY | 39.00 |
| 2026-08-11 | CCORF | -- | BUY | 46.00 |
| 2026-08-11 | Guggenheim | -- | BUY | 35.00 |
| 2026-08-06 | CCORF | -- | BUY | 46.00 |
| 2026-07-30 | CCORF | -- | BUY | 46.00 |
| 2026-07-23 | CCORF | -- | BUY | 46.00 |
| 2026-07-15 | J.P. Morgan | -- | BUY | 46.00 |
| 2026-06-29 | CCORF | -- | BUY | 46.00 |
| 2026-06-26 | Jefferies | -- | BUY | 60.00 |
| 2026-06-25 | Jefferies | -- | BUY | 60.00 |
| 2026-06-11 | CCORF | -- | BUY | 42.00 |
| 2026-06-10 | H.C. Wainwright | -- | BUY | 66.00 |
| 2026-06-09 | CCORF | -- | BUY | 42.00 |
| 2026-06-09 | B. Riley Securities | -- | BUY | 35.00 |
| 2026-06-09 | Guggenheim | -- | BUY | 32.00 |
| 2026-06-09 | H.C. Wainwright | -- | BUY | 66.00 |
| 2026-06-08 | Wolfe Research | -- | BUY | 35.00 |
| 2026-06-08 | Mizuho Securities | -- | BUY | 36.00 |
| 2026-06-08 | B. Riley Securities | -- | BUY | 35.00 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Buy
Analyst consensus
Buy
All 2 views agree: bullish.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Mixed
1
■ Upgrades■ Downgrades
- 1 upgrade vs 0 downgrades among tracked analyst rating changes.
- Most recent: Jefferies moved from Hold to Buy on 2026-06-25.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-06-25 | Jefferies | HOLD → BUY | 60.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2025/Q4 | 2026-03-05 | -- | -- | +36.28% |
| 2025/Q3 | 2025-11-04 | -- | ±18.41% | +0.00% (in line) |
| 2025/Q2 | 2025-08-05 | -- | ±42.88% | +4.86% (in line) |
| 2025/Q1 | 2025-05-12 | -- | -- | +14.91% |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 06:07:34 · For reference only, not investment advice and not tailored to your situation.